dr. Rani Soenen

Journal Article
A2
open access

Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study

Lisa Schots (UGent) , Rani Soenen (UGent) , Debby Thomas, Annelies Stockman (UGent) , Erwin Dreesen, Anke Eylenbosch (UGent) and Jo Lambert (UGent)

(2024) JEADV CLINICAL PRACTICE.

Add to list

Journal Article
A1
open access

Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort

Lisa Schots (UGent) , Rani Soenen (UGent) , Brigitte Blanquart (UGent) , Debby Thomas and Jo Lambert (UGent)

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(4). p.698-710

Add to list

PhD Thesis

Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making

Rani Soenen (UGent)

(2023)

Add to list

Journal Article
A1
open access

Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Rani Soenen (UGent) , Christophe Stove (UGent) , Alessio Capobianco, Hanne De Schutter, Marie Dobbelaere, Tahmina Mahjor, Merel Follens, Jo Lambert (UGent) and Lynda Grine (UGent)

(2022) JOURNAL OF CLINICAL MEDICINE. 11(11).

Add to list

Journal Article
A1
open access

Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Rani Soenen (UGent) , Zhigang Wang, Lynda Grine (UGent) , Erwin Dreesen, Lisa Schots (UGent) , Els Brouwers, Paul Declerck, Debby Thomas and Jo Lambert (UGent)

(2022) CLINICAL AND EXPERIMENTAL DERMATOLOGY. 47(7). p.1324-1336

Add to list

Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey

Lisa Schots (UGent) , Lynda Grine (UGent) , Rani Soenen (UGent) and Jo Lambert (UGent)

(2022) JOURNAL OF DERMATOLOGICAL TREATMENT. 33(3). p.1473-1481

Add to list

Journal Article
A2
open access

Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Pierre-Dominique Ghislain, Valérie Failla, Jo Lambert (UGent) , Rani Soenen (UGent) , Lynda Grine (UGent) , Julio Tannous, Françoise Guiot, Fabienne Willaert, Hugues Fierens, Mark Vandaele, et al.

(2021) JAAD INTERNATIONAL. 4. p.15-17

Add to list

Journal Article
A1
open access

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Nathalie Van den Berghe, Aurélie Truffot, Miet Peeters, Griet Compernolle, Els Brouwers, Rani Soenen (UGent) , Lynda Grine (UGent) , Ann Gils and Maya Imbrechts

(2020) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 189.

Add to list

Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study

F. Benhadou, PD. Ghislain, F. Guiot, F. Willaert, V. Del Marmol, Jo Lambert (UGent) , Rani Soenen (UGent) , H. Fierens and M. de la Brassinne

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(12). p.E837-E839

Add to list

Journal Article
A1
open access

Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis

N. Van den Berghe, Eline De Keyser (UGent) , Rani Soenen (UGent) , L. Meuleman, S. Lanssens, A. Gils and Jo Lambert (UGent)

(2020) BRITISH JOURNAL OF DERMATOLOGY. 182(2). p.390-397

Academic Bibliography

dr. Rani Soenen

Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study

Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort

Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making

Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey

Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study

Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis

Contents

Support

Contact